The store will not work correctly when cookies are disabled.
1-[3-(4-biphenyl)-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)]-3-phenol
ID: ALA212368
PubChem CID: 11602862
Max Phase: Preclinical
Molecular Formula: C22H20N4O
Molecular Weight: 356.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C22H20N4O/c1-25(2)22-24-23-21(26(22)19-9-6-10-20(27)15-19)18-13-11-17(12-14-18)16-7-4-3-5-8-16/h3-15,27H,1-2H3
Standard InChI Key: GYCSOBHVCMWJAF-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
11.7400 -18.1005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4099 -17.6081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1466 -16.8215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3171 -16.8282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0665 -17.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1277 -18.0044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1426 -18.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8646 -19.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5721 -18.8024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5531 -17.9730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8306 -17.5782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7436 -18.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0300 -19.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0351 -20.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7531 -20.5729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4676 -20.1510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4590 -19.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1865 -20.5564 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2935 -19.1969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3096 -20.0233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0320 -20.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7390 -19.9930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7189 -19.1635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9958 -18.7699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2834 -17.8798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6659 -17.3322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1178 -18.6885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 1 0
16 17 2 0
17 12 1 0
1 12 1 0
8 9 2 0
16 18 1 0
4 5 2 0
9 10 1 0
19 20 2 0
5 1 1 0
20 21 1 0
10 11 2 0
21 22 2 0
11 6 1 0
22 23 1 0
2 6 1 0
23 24 2 0
24 19 1 0
9 19 1 0
2 3 2 0
5 25 1 0
25 26 1 0
12 13 2 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.43 | Molecular Weight (Monoisotopic): 356.1637 | AlogP: 4.37 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.99 | CX Basic pKa: 2.28 | CX LogP: 4.94 | CX LogD: 4.94 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.59 | Np Likeness Score: -0.95 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |